Epclusa
Showing 26 - 50 of 65
Hepatitis C, Chronic, Lung Transplant Trial in Durham (Epclusa)
Terminated
- Hepatitis C, Chronic
- Lung Transplant
- Epclusa
-
Durham, North CarolinaDuke University Medical Center
Aug 20, 2019
Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)
Completed
- Hepatitis C Virus Infection
-
Seongnam-si, Gyeonggi-D, Korea, Republic of
- +21 more
Sep 29, 2021
HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence Trial in Regina (Genvoya, Epclusa, Biktarvy)
Unknown status
- HIV-1-infection
- +8 more
- Genvoya
- +2 more
-
Regina, Saskatchewan, CanadaSaskatchewan Health Authority
Dec 23, 2019
Hepatitis C Trial in Boston (Sofosbuvir/Velpatasvir Treatment for 14 days)
Withdrawn
- Hepatitis C
- Sofosbuvir/Velpatasvir Treatment for 14 days
-
Boston, MassachusettsMassachusetts General Hospital
Jan 16, 2020
Hepatitis C Virus Infection Trial in Worldwide (SOF/VEL)
Completed
- Hepatitis C Virus Infection
-
Los Angeles, California
- +26 more
Oct 5, 2020
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Hepatitis C, Chronic Trial in Kigali (sofosbubir/velpatasvir, sofosbubir/velpatasvir/voxilaprevir)
Unknown status
- Hepatitis C, Chronic
-
Kigali, RwandaRwanda Military Hospital
Sep 10, 2019
Transmission of Chronic Hepatitis C in Pregnancy
Unknown status
- Hepatitis C
- +2 more
- SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg
-
Cincinnati, OhioLindner Research Center at the Christ hospital
Jul 22, 2019
HCV Patients Receiving SOF-based or SOF-free DAAs
Completed
- Hepatitis C
- +2 more
- Sofosbuvir / Velpatasvir Oral Tablet
- +5 more
-
Douliu, Taiwan
- +1 more
Aug 6, 2019
Hepatitis C, Swallowing Disorder Trial in Nijmegen (velpatasvir)
Completed
- Hepatitis C
- Swallowing Disorder
-
Nijmegen, Gelderland, NetherlandsRadboud university medical Center
Oct 16, 2020
Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick
Recruiting
- Hepatitis C
- OraQuick HCV Antibody test (OraSure Technologies, Inc)
- +2 more
-
Clayton South, Victoria, Australia
- +5 more
Aug 16, 2022
HCV Trial in Bonn, 's-Hertogenbosch, Nijmegen (sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed)
Withdrawn
- HCV
- sofosbuvir/velpatasvir tablet
- sofosbuvir/velpatasvir crushed
-
Bonn, Germany
- +2 more
Dec 4, 2020
Chronic Hepatitis C Trial in Worldwide (SOF/VEL)
Completed
- Chronic Hepatitis C
-
Adelaide, South Australia, Australia
- +21 more
Feb 18, 2020
Hepatitis C Virus Infection Trial in Auckland (SOF/VEL)
Completed
- Hepatitis C Virus Infection
-
Auckland, New Zealand(unnamed)
Feb 5, 2019
Hepatitis C Virus Infection Trial in New Zealand, Puerto Rico, United States (VOX, SOF/VEL, RBV)
Hepatitis C Virus Infection Trial in New Zealand, Puerto Rico, United States (VOX, SOF/VEL)
Completed
- Hepatitis C Virus Infection
-
Los Angeles, California
- +33 more
Feb 18, 2020
Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, RBV, SOF/VEL)
Thalassemia, Hepatitis C Trial in Beirut (sofosbuvir/velpatasvir)
Completed
- Thalassemia
- Hepatitis C
-
Beirut, LebanonAmerican University of Beirut Medical Center
Oct 10, 2018
Hepatitis C Virus Infection Trial in Japan (SOF/VEL, RBV)
Completed
- Hepatitis C Virus Infection
-
Shimonoseki, Yamaguchi, Japan
- +32 more
Feb 1, 2019
COVID-19 Trial in Mansoura (Sofosbuvir 400 MG plus Daclatasvir 200mg)
Unknown status
- COVID-19
- Sofosbuvir 400 MG plus Daclatasvir 200mg
-
Mansoura, Dakahlyia, EgyptMansoura Faculty of Medicine
Feb 22, 2021
Hepatitis C Virus Infection Trial in India (SOF/VEL)
Completed
- Hepatitis C Virus Infection
-
New Delhi, Delhi, India
- +15 more
Feb 25, 2019
Hepatitis C Virus Infection Trial in Worldwide (SOF/VEL, RBV)
Completed
- Hepatitis C Virus Infection
-
San Diego, California
- +29 more
Oct 19, 2018